El Dr. Norberto Chávez tiene un mensaje para ti. Asiste al XX Congreso Nacional de Hepatología y pon al día tus conocimientos con expertos nacionales e internacionales. Hotel Hacienda Jurica, Santiago de Querétaro, del 9 al 12 de julio, 2025 #XXCongresoNacionalDeHepatologia

Ferroptosis fuels sepsis-induced liver injury—but there's hope!🔬Silencing Lipocalin-2 reduces oxidative stress & protects the liver. A promising step toward new treatments! 🧬 Read more in AoH: doi.org/10.1016/j.aohe… #Sepsis #LiverHealth #Ferroptosis

📢 New study in AoH: Adding rifaximin to corticosteroids or pentoxifylline showed no survival benefit for severe alcoholic hepatitis (SAH). 🔑 Key takeaway: MELD score remains the strongest predictor of short-term mortality. More insights 👉doi.org/10.1016/j.aohe… #LiverHealth

2D Shear-Wave Elastography (2D SWE) outshines DWI-based Virtual Elastography (µDiff) in staging liver fibrosis! 🎯 Larger AUCs make 2D SWE the go-to tool for advanced fibrosis & cirrhosis 📊 doi.org/10.1016/j.aohe… #Hepatology #LiverFibrosis #MedicalResearch

Mitochondria: Key players in MASLD progression!🧬 Imbalances in β-oxidation, oxidative stress, and mitophagy defects make them promising therapeutic targets🔍Unlock innovative treatments for steatotic liver disease. 🔗doi.org/10.1016/j.aohe… #MASLD #LiverHealth

📢 New research in Annals of Hepatology! FibroTouch® shows strong potential for diagnosing hepatic steatosis and fibrosis in MASLD patients, offering a convenient alternative to FibroScan®. 🔗 Read more: doi.org/10.1016/j.aohe… #Hepatology #MASLD #LiverHealth

📢 New in AoH! Tumor-associated macrophages drive cholangiocarcinoma progression and chemoresistance by activating the OSM-Yap-ID1 pathway. 🔗 Read more: [doi.org/10.1016/j.aohe…](doi.org/10.1016/j.aohe…) #Hepatology #Cholangiocarcinoma #LiverCancer #MedicalResearch

📢 New in AoH! This review explores the gut-liver axis and oxidative stress in MASLD, highlighting how gut dysbiosis and oxidative stress drive disease progression 🔗 Read more: [doi.org/10.1016/j.aohe…](doi.org/10.1016/j.aohe…) #Hepatology #MASLD #GutLiverAxis #LiverHealth

📢New in AoH Type 2 diabetes accelerates MASLD progression, increasing risks of advanced fibrosis, MASH, and liver-related mortality. Early interventions are critical! 🔗doi.org/10.1016/j.aohe…](doi.org/10.1016/j.aohe…) #Hepatology #MASLD #Type2Diabetes #LiverHealth

🦠New in AoH! An ultra-high-sensitivity HBsAg assay (iTACT-HBsAg) shows promise in safely guiding the cessation of nucleot(s)ide analogue therapy for HBV reactivation. 🔗 [doi.org/10.1016/j.aohe…](doi.org/10.1016/j.aohe…) #Hepatology #HBV #LiverHealth #PrecisionMedicine